The intravenous injection crisis in the United States is expected to ease: the first batch of imported materials are backed by factories in China and other places
123458005
发表于 2024-10-23 12:24:14
1167
0
0
After Hurricane Helena paralyzed the largest intravenous injection production base in the United States, the largest intravenous injection manufacturer in the country, Baxter International, is currently working to restore the delivery of this important medical product. During this period, many American medical institutions have postponed a large number of surgeries and taken other measures to save the few tight supplies.
Baite International recently announced that it expects to resume production at its Marion, North Carolina factory in stages by the end of this year.
Previously, Hurricane Helena, which ravaged the area in late September, caused severe damage to the factory and destroyed surrounding bridges and roads. The production of the factory has been suspended to this day, and this severe climate disaster has made the transportation of finished products from the Baite factory and the transportation of materials needed for the repair factory even more complex.
Baxter, headquartered in Deerfield, Illinois, USA, stated that there is currently no specific timeline for restoring the factory's production to pre hurricane levels.
However, the good news is that Baxter has intensified the production of intravenous injections at other global production bases and is working with federal regulatory agencies to obtain permission to import these products. Last weekend, the first batch of temporary imported products approved by the US Food and Drug Administration (FDA) arrived in the United States.
In its latest statement released last Thursday, Baxter announced that it began shipping to the United States from two overseas Baxter factories (Mexico and Spain) that previously had FDA import permits in mid October, and more goods are currently in transit.
The company has also started importing intravenous injections from its five international factories located in China (two factories), Canada, Ireland, and the UK, which just received temporary import approval from the FDA this month.
Baite Company expects that by the end of this year, there will be about 200 aircraft importing intravenous injections from Europe and Asia, totaling about 18000 tons of supplies.
Baite Company claims that with these products and other supplies, it can meet approximately 60% of the goods that customers typically receive. The company expects to increase the shipment volume of certain products in early November, thereby restoring the shipment volume of certain products to the usual 90% -100% by the end of the year.
Medical institutions in the United States are eagerly awaiting supplies
Currently, severe supply shortages have led some American hospitals and healthcare providers to rack their brains in trying to save on intravenous injection usage, including delaying surgeries in some cases.
Baite International is the largest manufacturer of intravenous infusion and dialysate in the United States, so the impact of supply restrictions and interruptions can be extremely significant. Intravenous infusion has various medical uses. Some illnesses, such as dehydration, can be treated with alternative methods. But other illnesses, such as organ transplant surgery, are irreplaceable.
Brigham General Hospital, located in Boston, USA, announced in a statement that it resumed all surgical schedules last week after postponing some elective surgeries for several days to save intravenous infusion supply.
Donald Yealy, Chief Medical Officer of the University of Pittsburgh Medical Center, stated that doctors and nurses at the hospital are using alternative hydration methods (such as electrolyte drinks) as much as possible to save infusion volume for patients who require intravenous fluids. Yealy said, "This alone can save a lot of intravenous infusion usage
Currently, other healthcare manufacturers have also increased their production efforts in an attempt to fill the gap. German healthcare giant B Braun Group of Cos.'s medical technology company B Braun Medical stated that the company has increased production at its intravenous injection factories located in Irvine, California and Daytona Beach, Florida, and is taking other measures to provide intravenous injections.
It is worth mentioning that in recent months, the shortage of intravenous injections worldwide has not only occurred in the United States. The Australian Medicines Agency also added intravenous injection to the list of drugs in short supply on July 26th.
Industry insiders have stated that physiological saline (intravenous injection) is composed of sodium chloride and distilled water, with sodium chloride accounting for over 70% of the total production cost and having a relatively low added value. Therefore, there is not enough global enterprise engaged in the production of physiological saline solution.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- When will the results of the US election be announced? The important node viewing guide has arrived
- Double Eleven is here! Are e-commerce giants experiencing discounts in their stock prices? In the past month, Pinduoduo offers a 20% discount, Alibaba offers a 15% discount, and JD.com offers a 10% discount!
- Robin Lee: Agents will usher in an era when only ideas can make money
- Can the Federal Reserve cut interest rates next month? Tonight's crucial test has arrived
- The November "report card" of new energy vehicle brands has arrived! The ideal delivery volume has declined month on month
- Can the Federal Reserve achieve a 'triple decline'? The first 'big exam' off farm is coming tonight!
- What will be the pace of interest rate cuts in November when the US sees a rebound in non farm payrolls but an increase in unemployment? The latest perspective from the institution has arrived
- Extreme Krypton vehicle caught fire? The executive responded
- Heavy night! The Federal Reserve cuts interest rates by 25 basis points, causing the US dollar to soar instantly! The latest interpretation has arrived
- There is no upper limit, and the year-end bonuses of large factories are rolling up again! Jingdong made a huge 20 salary, and the ByteDance also rose sharply
-
隔夜株式市場 世界の主要指数は金曜日に多くが下落し、最新のインフレデータが減速の兆しを示したおかげで、米株3大指数は大幅に回復し、いずれも1%超上昇した。 金曜日に発表されたデータによると、米国の11月のPC ...
- SNT
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
長年にわたって、昔の消金大手の捷信消金の再編がようやく地に着いた。 天津銀行の発表によると、同行は京東傘下の2社、対外貿易信託などと捷信消金再編に参加する。再編が完了すると、京東の持ち株比率は65%に達し ...
- SNT
- 3 天前
- 支持
- 反对
- 回复
- 收藏
-
【GPT-5屋台で大きな問題:数億ドルを燃やした後、OpenAIは牛が吹くのが早いことを発見した】OpenAIのGPT-5プロジェクト(Orion)はすでに18カ月を超える準備をしており、関係者によると、このプロジェクトは現在進 ...
- SNT
- 昨天 13:11
- 支持
- 反对
- 回复
- 收藏
-
【英偉達はExBody 2システムを発売して2足ロボットのバランスと適応能力を強化】12月18日、英偉達、MIT、カリフォルニア大学は共同で最新の研究を発表し、ロボットが「固定シナリオ」による運動限界を打破し、ロボ ...
- smile929
- 昨天 19:00
- 支持
- 反对
- 回复
- 收藏